Mankind Pharma Limited (BOM:543904)

India flag India · Delayed Price · Currency is INR
2,500.70
-56.75 (-2.22%)
At close: Aug 26, 2025
-2.22%
Market Cap1.02T
Revenue (ttm)129.10B
Net Income (ttm)18.93B
Shares Outn/a
EPS (ttm)46.42
PE Ratio53.89
Forward PE45.38
Dividend1.00 (0.04%)
Ex-Dividend DateAug 8, 2025
Volume9,150
Average Volume11,853
Open2,535.50
Previous Close2,557.45
Day's Range2,491.00 - 2,565.30
52-Week Range2,115.50 - 3,050.00
Betan/a
RSI44.26
Earnings DateJul 31, 2025

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory diseases, etc. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, oral contraceptives, antacid powders, vitamin a... [Read more]

Industry Pharmaceutical Preparations
Founded 1991
Employees 26,978
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543904
Full Company Profile

Financial Performance

In 2024, Mankind Pharma's revenue was 122.07 billion, an increase of 18.98% compared to the previous year's 102.60 billion. Earnings were 19.91 billion, an increase of 4.08%.

Financial Statements

News

There is no news available yet.